NasdaqCM - Delayed Quote USD
ImmuCell Corporation (ICCC)
5.50
+0.04
+(0.73%)
At close: April 23 at 4:00:00 PM EDT
Insider Roster
Insider roster data is derived solely from the last 24 months of Form 3 & Form 4 SEC filings.
| Individual or Entity | Most Recent Transaction | Date | Shares Owned as of Transaction Date |
|---|---|---|---|
| BRIGHAM MICHAEL F Chief Executive Officer | Conversion of Exercise of derivative security | Dec 28, 2018 | 204,752 |
| BROCKMANN BOBBI JO Director | Stock Award(Grant) | Dec 8, 2020 | 8,521 |
| CRABB JOSEPH H Officer | Conversion of Exercise of derivative security | Nov 26, 2018 | 141,845 |
| CUNNINGHAM DAVID Director | Purchase | Jun 13, 2022 | 16,000 |
| PESSIN BRIAN L Beneficial Owner of more than 10% of a Class of Security | Purchase | Jul 27, 2017 | 70,000 |
| PESSIN NORMAN H Beneficial Owner of more than 10% of a Class of Security | Purchase | Jul 27, 2017 | -- |
| RHODES LINDA Director | Purchase | Jan 29, 2016 | 7,157 |
| ROTHSCHILD JONATHAN E Director | Stock Award(Grant) | Jun 3, 2021 | 514,003 |
| TOMSCHE DAVID SCOTT Director | Purchase | Mar 11, 2020 | 85,519 |
| WAINMAN PAUL R Director | Stock Award(Grant) | Mar 11, 2019 | 6,269 |
Related Tickers
CSBR Champions Oncology, Inc.
7.87
+0.13%
MLECW Moolec Science SA
0.0170
+65.05%
LIXT Lixte Biotechnology Holdings, Inc.
1.3000
+15.04%
NRXS NeurAxis, Inc.
2.4168
+23.94%
RADX Radiopharm Theranostics Limited
4.0500
-3.34%
GYRE Gyre Therapeutics, Inc.
9.19
+6.37%
CSCI COSCIENS Biopharma Inc.
3.1100
+1.63%
GHRS GH Research PLC
9.50
+0.96%
LVTX LAVA Therapeutics N.V.
1.3600
-1.45%
XBIT XBiotech Inc.
3.1600
+1.28%